Created: 01/31/2014 6:51 PM WDIO.com
By: MATTHEW PERRONE, AP Health Writer
WASHINGTON (AP) - The Food and Drug Administration said Friday it is reviewing the safety of popular testosterone drugs for men in light of recent studies suggesting they can increase the risk of heart attack, stroke and death.
A study published earlier this week suggested testosterone therapy could double the risk of those problems in men older than 65. Another study published in November found that the hormone increased the risk by 30 percent.
The FDA said it is evaluating information from those studies and others but hasn't yet reached any conclusion.
The investigation comes amid an advertising blitz for testosterone gels, patches and injections marketed for low sex drive, fatigue and other age-related ailments in men.
U.S. prescriptions for testosterone have increased more than five-fold in recent years, with sales over $1.6 billion.
Testosterone injections have long been used for men with hypogonadism, a disorder defined by low testosterone caused by injury or infection to the reproductive organs.
But the latest marketing push by drugmakers is for easy-to-use gels and patches that are aimed at a much broader population of otherwise healthy older men with low levels of testosterone, the male hormone that begins to decline in the body after age 40.
Drugmakers and many doctors claim testosterone therapy can reverse some unpleasant of the signs of aging - ranging from insomnia to erectile dysfunction. Those claims are mostly based on short-term studies.
The National Institute on Aging is currently conducting a long-term, 800-man trial to definitively answer whether testosterone therapy improves walking ability, sexual function, energy, memory and blood cell count in men 65 years and older.
Meanwhile the market for testosterone replacements has grown increasingly crowded.
The top-selling product in the field is Abbvie's Androgel, which is applied to the shoulders and arms. Watson Pharmaceuticals markets the Androderm patch, which slowly releases testosterone into the bloodstream. Fortesta is another testosterone gel from Endo Pharmaceuticals, and Eli Lilly's Axiron is an underarm gel that rolls on like deodorant.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Charge Against Superior Woman in Controversial Arrest Video Dismissed
A judge has dismissed a charge against a woman seen in a video of a controversial Superior arrest. At a hearing Friday, Judge Kelly Thimm approved a motion to dismiss a misdemeanor disorderly conduct charge against Natasha Lancour.
Three Attempted Murder Charges Filed Against Woman in Douglas Co. Shootout
Twenty two-year old Jessica Gehl of Lake Nebagamon was charged with three counts of attempted first degree intentional murder Friday after she allegedly pulled a gun on her mother and then opened fire on authorities Wednesday. Gehl was also charged with first-degree recklessly endangering safety.
Reinert 'Strongly Considering' Running for Duluth Mayor
When Duluth Mayor Don Ness announced earlier this month that he would not seek re-election, many people were surprised. On Friday, Sen. Roger Reinert said he is strongly considering entering the race.
Dayton, Johnson Show Fire in Final Governor Debate
Democratic Gov. Mark Dayton and Republican nominee Jeff Johnson ended their series of debates Friday much like they began, with the incumbent hailing big-picture successes and his rival saying too many things went awry over the past four years.
KSTP/SurveyUSA: Health Care, Taxes Most Important to Voters
When it comes to making choices for political candidates on Election Day, Minnesota voters say health care and taxes are the issues most important to them.